Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly  Settings
HAE [NYSE]
Haemonetics Corp.
Healthcare | Medical Instruments & Supplies | USA
financial highlights | statements
Index- P/E55.78 EPS (ttm)0.74 Insider Own0.64% Shs Outstand51.64M Perf Week3.48%
Market Cap2.13B Forward P/E15.70 EPS next Y2.63 Insider Trans3.12% Shs Float51.38M Perf Month6.92%
Income38.80M PEG4.52 EPS next Q0.47 Inst Own- Short Float6.25% Perf Quarter0.39%
Sales891.99M P/S2.39 EPS this Y-42.73% Inst Trans-0.87% Short Ratio10.66 Perf Half Y1.72%
Book/sh14.89 P/B2.77 EPS next Y12.88% ROA3.27% Target Price44.60 Perf Year16.58%
Cash/sh3.47 P/C11.90 EPS next 5Y12.33% ROE5.17% 52W Range32.69 - 44.44 Perf YTD1.08%
Dividend- P/FCF- EPS past 5Y-5.24% ROI3.76% 52W High-7.11% Beta0.43
Dividend %- Quick Ratio2.30 Sales past 5Y11.55% Gross Margin48.00% 52W Low26.28% ATR0.74
Employees2337 Current Ratio3.32 Sales Q/Q33.90% Oper. Margin6.33% RSI (14)62.08 Volatility2.37% 1.87%
OptionableYes Debt/Eq0.62 EPS Q/Q-30.59% Profit Margin4.35% Rel Volume0.55 Prev Close41.30
ShortableYes LT Debt/Eq0.59 EarningsMay 01 BMO Payout- Avg Volume301.35K Price41.28
Recom2.40 SMA204.43% SMA502.67% SMA2002.88% Volume164,271 Change-0.05%
13-Sep-12Initiated The Benchmark Company Buy $89
03-Aug-11Upgrade Barrington Research Mkt Perform → Outperform $70
29-Jul-11Downgrade Morgan Keegan Outperform → Mkt Perform $76
04-Apr-11Downgrade Barrington Research Outperform → Mkt Perform
06-Jan-10Initiated Barrington Research Outperform $67
18-Nov-09Initiated Morgan Keegan Outperform
03-Feb-09Reiterated Maxim Group Buy $72 → $75
28-Jan-09Initiated Maxim Group Buy $72
03-Sep-08Upgrade Avondale Mkt Perform → Mkt Outperform $72
01-Feb-08Reiterated Dawson James Buy $55 → $65
22-Feb-07Initiated Susquehanna Financial Positive
23-May-13 04:39PM  Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference PR Newswire
20-May-13 02:08PM  Interesting HAE Put For July at TheStreet
10:33AM  HAEMONETICS CORP Files SEC form 10-K, Annual Report EDGAR Online
17-May-13 10:46AM  Mark W. Oelschlager, Portfolio Manager at Oak Associates, Ltd., Interviews with The Wall Street Transcript: A Health Sciences Fund with a Long-Term Focus Wall Street Transcript
16-May-13 07:00PM  Haemonetics Corporation - Analyst/Investor Day at Seeking Alpha
04:10PM  HAE Crosses Above Key Moving Average Level at TheStreet
08-May-13 02:22PM  Bargain Hunters Take Note: Insider Cluster-Buying At HAE at Forbes
06-May-13 10:09AM  Insiders Buy the Holdings of XSLV at Forbes
03-May-13 02:55PM  HAE Beats on Earnings, Revs in Line Zacks
04:46AM  HAEMONETICS CORP Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
02-May-13 01:20PM  Haemonetics Closes Hemerus Acquisition Zacks
09:21AM  Haemonetics upgraded to Buy from Hold at Craig-Hallum at theflyonthewall.com
01-May-13 04:23PM  Haemonetics Corp. Becomes Oversold (HAE) at TheStreet
01:02PM  Haemonetics Completes Hemerus Medical Acquisition at Motley Fool
12:10PM  Haemonetics Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
09:31AM  Haemonetics Earnings: Everything You Must Know Now at Wall St. Cheat Sheet
08:00AM  Haemonetics Corporation Earnings Call scheduled for 8:00 am ET today CCBN
07:49AM  Haemonetics Corporation Earnings Call scheduled for 8:00 am ET today CCBN
07:19AM  InPlay: Haemonetics beats by $0.02, reports revs in-line; guides FY14 EPS above consensus Briefing.com
07:07AM  Q4 2013 Haemonetics Corporation Earnings Release - Before Market Open CCBN
07:00AM  Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 201 PR Newswire
06:59AM  Haemonetics Completes Hemerus Medical, LLC Acquisition PR Newswire
12:34AM  HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Costs Associated with Exit or Dis EDGAR Online
30-Apr-13 08:16PM  Haemonetics Earnings Preview: Get Ahead of the Analysts at Wall St. Cheat Sheet
24-Apr-13 02:30PM  Covidien Likely to Beat Earnings? Zacks
08:00AM  Haemonetics Sets Date for Investor/Analyst Meeting PR Newswire
23-Apr-13 02:00PM  Will Stryker Miss Earnings this Quarter? Zacks
22-Apr-13 02:00PM  Will CR Bard Miss Earnings this Quarter? Zacks
17-Apr-13 11:23AM  Haemonetics (HAE) Shares Cross Below 200 DMA at TheStreet
15-Apr-13 04:49PM  Haemonetics Corp. Moves Up In Market Cap Rank, Passing Apollo Group at Forbes
02:10PM  Haemonetics Back to Neutral Zacks
10-Apr-13 09:06AM  Did Haemonetics Squander Its Latest Sales Increase? at Motley Fool
05-Apr-13 12:48PM  Palls New Center of Excellence Zacks
02-Apr-13 01:12AM  Don't Get Too Worked Up Over Haemonetics's Earnings at Motley Fool
01-Apr-13 04:00PM  Haemonetics Sets Date for Fourth Quarter Fiscal Year 2013 Earnings Release: Wednesday, May 1, 2013 PR Newswire
18-Mar-13 02:40PM  A Board Member Bet $1.1 Million on This Stock at Motley Fool
15-Mar-13 12:07PM  Larger Names in Ortho and Cardio Go Up in the Double Digits in Early 2013, But How Long Can This Last? Headwinds Regarding U.S. Utilization and European Economic Performance Pose Questions on this Bullishness Wall Street Transcript
13-Mar-13 01:52PM  Covidien launches trio of hernia care products at bizjournals.com
06-Mar-13 12:18PM  PLL Expands into Research Zacks
26-Feb-13 06:10PM  Haemonetics Corporation Presents at Citi 2013 Global Healthcare Conference, Feb-26-2013 01:30 PM at Seeking Alpha
25-Feb-13 08:00AM  Haemonetics to Present at The Raymond James Institutional Investors Conference PR Newswire
14-Feb-13 03:50PM  Military veterans avoid job-seeking obstacle course, join tech boot camp at bizjournals.com
08:00AM  Haemonetics' CMO, Mark Popovsky, Joins U.S. Health and Human Services Advisory Committee on Blood Safety PR Newswire
13-Feb-13 08:00AM  Haemonetics to Present at Citi 2013 Global Healthcare Conference PR Newswire
07-Feb-13 01:12PM  Don't Get Too Worked Up Over Haemonetics's Earnings at Motley Fool
01:04PM  HAEMONETICS CORP Financials EDGAR Online Financials
06-Feb-13 04:00PM  Haemonetics to Present at Leerink Swann 2013 Global Healthcare Conference PR Newswire
05-Feb-13 09:04AM  1 Reason to Expect Big Things from Haemonetics at Motley Fool
01-Feb-13 05:13PM  HAEMONETICS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
09:18AM  Mixed Quarter for Haemonetics Zacks
31-Jan-13 12:28PM  Zimmer Beats Estimates Zacks
30-Jan-13 06:03PM  NYSE stocks posting largest percentage decreases AP -5.76%
01:17PM  NYSE stocks posting largest percentage decreases AP
12:04PM  Haemonetics stock plunges on Q3 profit drop at bizjournals.com
11:02AM  Health-care stocks insiders are betting on at MarketWatch
08:03AM  Haemonetics 3Q profit drops 46 pct as costs rise AP
08:00AM  Haemonetics Corporation Earnings Call scheduled for 8:00 am ET today CCBN
07:46AM  Haemonetics Corporation Earnings Call scheduled for 8:00 am ET today CCBN
07:07AM  Q3 2013 Haemonetics Corporation Earnings Release - Before Market Open CCBN
06:16AM  InPlay: Haemonetics beats by $0.02, misses on revs; reaffirms FY13 EPS guidance, guides FY13 revs below consensus; reaffirms FY14 EPS guidance Briefing.com
06:05AM  HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
06:00AM  Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70 PR Newswire
29-Jan-13 05:48PM  Cyberonics Approves Share Buyback Zacks
02:18PM  Reiterate Baxter at Neutral Zacks
08:18AM  Illumina Posts an Impressive 4Q Zacks
23-Jan-13 03:14PM  Momentum Players Have Lots To Like About Haemonetics at Forbes
11:38AM  Dismal 4Q for Quest Diagnostics Zacks
08:08AM  PetMed Revs in Line, Margins Up Zacks
01:00AM  Haemonetics Corp. (HAE): Zacks Rank Buy Zacks
21-Jan-13 02:08PM  Covidien's Device for Hypertension Zacks
04:24AM  Zacks Rank #1 Additions for Monday Zacks
18-Jan-13 09:06AM  Here's How Haemonetics May Be Failing You at Motley Fool
17-Jan-13 01:58PM  Medtronic Expands AF Product Line Zacks
11:08AM  DGX to Sell HemoCue Zacks
14-Jan-13 06:11AM  Zacks Bull and Bear of the Day Highlights: Haemonetics, Iron Mountain, Aetna Inc., UnitedHealth Group Inc. and CIGNA Corp. Zacks
01:00AM  Bull of the Day: Haemonetics Zacks
11-Jan-13 04:46PM  Haemonetics Larger Than S&P 500 Component Apollo Group at Forbes
02:58PM  Haemonetics Upgraded to Outperform Zacks
01:58PM  Edwards Upgraded to Neutral Zacks
10:18AM  Volcano Corporation Stays Neutral Zacks
09-Jan-13 04:00PM  Haemonetics Sets Date for Third Quarter Fiscal Year 2013 Earnings Release: January 30, 2013 PR Newswire
07-Jan-13 05:08PM  Haemonetics to Update on Growth Zacks
04-Jan-13 04:10PM  Haemonetics to Provide an Update on Key Growth Initiatives at J.P. Morgan Health Care Conference PR Newswire
21-Dec-12 04:56PM  Haemonetics to Present at the 31st Annual J.P. Morgan Health Care Conference PR Newswire
20-Dec-12 11:56AM  Allscripts Shakeup Shakes Down Shares at Motley Fool
11-Dec-12 04:26PM  5 Biotechs With Short Squeeze Potential Hitting New 52 Week Highs at Seeking Alpha
10-Dec-12 10:15AM  NASDAQ to cancel Haemonetics trades at or below $36.28 from 9:29-9:30 am ET theflyonthewall.com
03-Dec-12 09:57PM  Haemonetics Announces 2-For-1 Split and 2 Stocks Enjoying 52-Week Highs at Wall St. Cheat Sheet
05:16PM  Haemonetics Announces 2-For-1 Split and 2 Stocks Enjoying 52-Week Highs at Wall St. Cheat Sheet
01:26PM  Haemonetics starts 2-for-1 stock split AP
08:06AM  InPlay: Haemonetics has effected a 2-for-1 split of all shares of its common stock Briefing.com
08:00AM  Haemonetics Effects 2-For-1 Split of Its Common Stock PR Newswire
01-Dec-12 01:03AM  This Metric Suggests You're Right to Own Haemonetics. at Motley Fool
25-Nov-12 01:16AM  Why Haemonetics's Earnings May Not Be So Hot at Motley Fool
23-Nov-12 01:02AM  Here's Why Haemonetics's Earnings Are Worse Than They Look at Motley Fool
14-Nov-12 01:04PM  HAEMONETICS CORP Financials EDGAR Online Financials
07-Nov-12 05:25PM  HAEMONETICS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
06-Nov-12 11:12AM  Bargain Hunters Take Note: Insider Cluster-Buying At HAE at Forbes
01:10AM  Haemonetics Passes This Key Test at Motley Fool
31-Oct-12 09:30AM  Haemonetics Reiterated at Outperform With $88 Target and 1 Stock Analysis to Track at Wall St. Cheat Sheet
Haemonetics Corporation develops and manufactures automated blood component collection and surgical blood salvage devices for plasma fractionators, blood collectors, and hospitals. The company's medical device systems automate the collection and processing of donated blood components, assess likelihood for blood loss, salvage and process blood from surgery patients, and dispense and track blood inventory. Its plasma products include PCS brand plasma collection equipment and consumables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain. The company's blood center products comprise MCS automated platelet system to collect one or more therapeutic doses of platelets during a single donation by a volunteer blood donor; SafeTrace and El Dorado Donor donation and blood unit management systems to automate and track blood center operations; Hemasphere software solution to support blood drive planning; and Donor Doc and e-Donor software to enhance recruitment and retention. Its hospital products include TEG Thrombelastograph Hemostasis Analyzer that measures patient's hemostasis and ability to form and maintain blood clots; and surgical blood salvage systems, such as Cell Saver for rapid and high-volume blood loss cardiovascular surgeries, Cell Saver Elite to minimize allogeneic blood use for medium to high blood loss surgeries, cardioPAT system for lower blood loss cardiovascular procedures, and OrthoPAT system for lower and slower blood loss orthopedic procedures. The company also provides SafeTrace TX and BloodTrack products that manage blood product inventory, patient cross-matching, and transfusion; and IMPACT Online, which monitors and measures hospital's blood management practices. Haemonetics Corporation markets its products through direct sales force and distributors. The company was founded in 1971 and is based in Braintree, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LINDOP CHRISTOPHER JCFO & EVP Business DevelopmentMay 21Option Exercise27.2842,8821,169,60773,992May 23 04:59 PM
LINDOP CHRISTOPHER JCFO & EVP Business DevelopmentMay 21Sale42.0042,8821,801,04431,110May 23 04:59 PM
Kelly Michael PPresident, Global MarketsMay 14Option Exercise27.491,40038,47913,136May 16 06:21 PM
Kelly Michael PPresident, Global MarketsMay 14Sale39.661,40055,52611,736May 16 06:21 PM
BEST LAWRENCE CDirectorMay 03Option Exercise26.3812,000316,56020,352May 07 04:17 PM
BEST LAWRENCE CDirectorMay 03Sale38.3212,000459,8308,352May 07 04:17 PM
CONCANNON BRIANPresident & CEOMay 01Option Exercise11.7213,000152,333125,798May 02 03:19 PM
CONCANNON BRIANPresident & CEOMay 01Sale38.6613,000502,604115,798May 02 03:19 PM
LINDOP CHRISTOPHER JCFO & EVP Business DevelopmentApr 30Buy32.7341213,48331,522May 02 07:19 PM
HANLON SUSAN MVP FinanceApr 30Buy32.732458,01816,751May 02 07:19 PM
FORISH JOSEPH JVP, Human ResourcesApr 30Buy32.7361520,12617,279May 02 07:19 PM
ALLEN PETER MPresident, Global PlasmaApr 30Buy32.7345114,75926,797May 02 07:18 PM
Helsel DaveEVP, Global ManufacturingApr 30Buy32.732728,9016,856May 02 07:18 PM
Jesse SandraChief Legal OfficerApr 30Buy32.7361420,0938,680May 02 07:18 PM
White JonathanChief Scientific and TechnogyApr 30Buy32.7361520,12625,342May 02 07:19 PM
Kelly Michael PPresident, Global MarketsApr 12Option Exercise27.491,40038,47913,136Apr 16 03:30 PM
Kelly Michael PPresident, Global MarketsApr 12Sale40.931,40057,29511,736Apr 16 03:30 PM
ALLEN PETER MPresident, Global PlasmaApr 03Option Exercise10.7322,828244,94449,174Apr 05 04:23 PM
ALLEN PETER MPresident, Global PlasmaApr 03Sale41.4422,828946,00426,346Apr 05 04:23 PM
CONCANNON BRIANPresident & CEOApr 01Option Exercise11.7410,288120,772126,286Apr 03 05:10 PM
CONCANNON BRIANPresident & CEOApr 01Sale41.9410,288431,472116,286Apr 03 05:10 PM
Kelly Michael PPresident, Global MarketsMar 14Option Exercise27.491,40038,47913,136Mar 18 03:55 PM
Kelly Michael PPresident, Global MarketsMar 14Sale41.141,40057,58911,736Mar 18 03:55 PM
CONCANNON BRIANPresident & CEOMar 01Option Exercise14.7913,000192,315126,286Mar 05 01:38 PM
CONCANNON BRIANPresident & CEOMar 01Sale41.0613,000533,811116,286Mar 05 01:38 PM
White JonathanVP Research and DevelopmentFeb 26Sale40.693,000122,0700Feb 28 04:36 PM
Kelly Michael PPresident, Global MarketsFeb 14Option Exercise27.491,40038,47913,136Feb 19 05:25 PM
Kelly Michael PPresident, Global MarketsFeb 14Sale41.711,40058,39411,736Feb 19 05:25 PM
CONCANNON BRIANPresident & CEOFeb 01Option Exercise14.7913,000192,315126,286Feb 05 12:35 PM
CONCANNON BRIANPresident & CEOFeb 01Sale41.9613,000545,466116,286Feb 05 12:35 PM
Kelly Michael PPresident, Global MarketsJan 14Option Exercise27.491,40038,47913,136Jan 16 04:17 PM
Kelly Michael PPresident, Global MarketsJan 14Sale42.291,40059,21111,736Jan 16 04:17 PM
CONCANNON BRIANPresident & CEOJan 07Option Exercise14.7913,000192,315126,286Jan 08 05:17 PM
CONCANNON BRIANPresident & CEOJan 07Sale41.4713,000539,172116,286Jan 08 05:17 PM
ALLEN PETER MPresident, Global PlasmaJan 04Option Exercise20.5153,2881,092,73759,634Jan 08 05:16 PM
HANLON SUSAN MVP FinanceJan 04Option Exercise13.0510,000130,52526,506Jan 08 05:17 PM
HANLON SUSAN MVP FinanceJan 04Sale41.6610,000416,57016,506Jan 08 05:17 PM
ALLEN PETER MPresident, Global PlasmaJan 04Sale41.6253,2882,217,81726,346Jan 08 05:16 PM
GELBMAN RONALD GDirectorDec 13Option Exercise18.8324,000451,89040,914Dec 17 03:47 PM
GELBMAN RONALD GDirectorDec 13Sale40.0711,310453,20228,914Dec 17 03:47 PM
Nighan Warren JRVP WW Q&R AffairsDec 11Option Exercise30.677,684235,66816,166Dec 13 07:48 AM
Nighan Warren JRVP WW Q&R AffairsDec 11Sale40.218,258332,0717,908Dec 13 07:48 AM
CONCANNON BRIANPresident & CEODec 03Option Exercise14.7913,000192,315126,286Dec 05 02:03 PM
CONCANNON BRIANPresident & CEODec 03Sale40.7513,000529,738116,286Dec 05 02:03 PM
LINDOP CHRISTOPHER JCFO & Vice President ofNov 20Sale80.9527822,50415,198Nov 21 01:13 PM
KROLL MARK WDirectorNov 19Option Exercise49.924,592229,2338,768Nov 21 01:12 PM
KROLL MARK WDirectorNov 19Sale80.134,592367,9574,176Nov 21 01:12 PM
MERRIMAN RONALDDirectorNov 19Sale80.981,00881,6285,168Nov 21 01:13 PM
KROLL MARK WDirectorNov 16Option Exercise52.766,000316,56010,176Nov 20 10:59 AM
KROLL MARK WDirectorNov 16Sale79.676,000478,0334,176Nov 20 10:59 AM
GRANADILLO PEDRO PDirectorNov 12Option Exercise38.4716,000615,51016,626Nov 14 05:35 PM
GRANADILLO PEDRO PDirectorNov 12Sale80.4016,0001,286,3416,626Nov 14 05:35 PM
CONCANNON BRIANPresident & CEONov 01Option Exercise29.596,500192,31563,143Nov 05 05:59 PM
HANLON SUSAN MVP FinanceNov 01Buy61.461197,3138,253Nov 05 05:59 PM
Helsel DaveVP, Global ManufacturingNov 01Buy61.461448,8503,456Nov 05 05:59 PM
Jesse SandraVP & CLONov 01Buy61.4628517,5154,033Nov 05 05:59 PM
LINDOP CHRISTOPHER JCFO & Vice President ofNov 01Buy61.461328,11215,476Nov 05 06:00 PM
ALLEN PETER MPresident, Global PlasmaNov 01Buy61.461136,94413,173Nov 05 05:58 PM
CONCANNON BRIANPresident & CEONov 01Sale81.826,500531,86058,143Nov 05 05:59 PM
ALLEN PETER MPresident, Global PlasmaOct 08Option Exercise21.4610,000214,60021,910Oct 10 11:10 AM
ALLEN PETER MPresident, Global PlasmaOct 08Sale81.0910,000810,93311,910Oct 10 11:10 AM
CONCANNON BRIANPresident & CEOOct 01Option Exercise29.596,500192,31553,171Oct 03 05:14 PM
CONCANNON BRIANPresident & CEOOct 01Sale80.736,500524,72048,171Oct 03 05:14 PM
FORISH JOSEPH JVP, Human ResourcesSep 13Option Exercise52.765,373283,47913,870Sep 17 11:47 AM
FORISH JOSEPH JVP, Human ResourcesSep 13Sale80.005,373429,8408,497Sep 17 11:47 AM
ALLEN PETER MPresident, Global PlasmaSep 10Option Exercise21.462,10045,06614,010Sep 12 06:47 PM
ALLEN PETER MPresident, Global PlasmaSep 10Sale75.642,100158,85011,910Sep 12 06:47 PM
FOOTE SUSAN BARTLETTDirectorSep 07Option Exercise52.766,000316,56010,107Sep 12 10:10 AM
FOOTE SUSAN BARTLETTDirectorSep 07Sale75.846,000455,0205,176Sep 12 10:10 AM
LINDOP CHRISTOPHER JCFO & Vice President ofSep 04Option Exercise49.1161,7833,034,43454,316Sep 06 06:37 PM
CONCANNON BRIANPresident & CEOSep 04Option Exercise29.596,500192,31553,171Sep 06 06:37 PM
CONCANNON BRIANPresident & CEOSep 04Sale73.686,500478,92448,171Sep 06 06:37 PM
LINDOP CHRISTOPHER JCFO & Vice President ofSep 04Sale74.3461,7834,593,18013,771Sep 06 06:37 PM
GELBMAN RONALD GDirectorAug 23Option Exercise44.746,000268,44018,417Aug 27 05:07 PM
GELBMAN RONALD GDirectorAug 23Sale71.906,000431,40012,417Aug 27 05:07 PM
GRANADILLO PEDRO PDirectorAug 13Option Exercise44.746,000268,44012,626Aug 15 06:06 PM
GRANADILLO PEDRO PDirectorAug 13Sale70.056,000420,3106,626Aug 15 06:06 PM
CONCANNON BRIANPresident & CEOAug 01Option Exercise29.596,500192,31553,171Aug 02 04:23 PM
CONCANNON BRIANPresident & CEOAug 01Sale71.746,500466,30048,171Aug 02 04:23 PM
ALLEN PETER MPresident, Global PlasmaJul 09Option Exercise21.4610,000214,60021,910Jul 11 05:18 PM
HANLON SUSAN MVP FinanceJul 09Option Exercise52.767,282384,19814,727Jul 11 05:21 PM
HANLON SUSAN MVP FinanceJul 09Sale73.987,282538,7517,445Jul 11 05:21 PM
ALLEN PETER MPresident, Global PlasmaJul 09Sale73.9810,000739,80011,910Jul 11 05:18 PM
CONCANNON BRIANPresident & CEOJul 02Option Exercise32.684,500147,04551,171Jul 05 01:42 PM
CONCANNON BRIANPresident & CEOJul 02Sale74.014,500333,06348,171Jul 05 01:42 PM
FORISH JOSEPH JVP, Human ResourcesJun 29Option Exercise52.765,000263,80013,497Jul 03 04:49 PM
FORISH JOSEPH JVP, Human ResourcesJun 29Sale74.005,000370,0008,497Jul 03 04:49 PM
FORISH JOSEPH JVP, Human ResourcesJun 21Option Exercise48.2012,000578,34020,497Jun 25 05:18 PM
FORISH JOSEPH JVP, Human ResourcesJun 21Sale71.1412,000853,6568,497Jun 25 05:18 PM
FORISH JOSEPH JVP, Human ResourcesJun 20Option Exercise48.2024,0001,156,68021,497Jun 21 05:05 PM
FORISH JOSEPH JVP, Human ResourcesJun 20Sale72.3124,0001,735,4058,497Jun 21 05:05 PM
FORISH JOSEPH JVP, Human ResourcesJun 19Option Exercise48.2014,000674,73022,497Jun 21 05:05 PM
FORISH JOSEPH JVP, Human ResourcesJun 19Sale72.3514,0001,012,9398,497Jun 21 05:05 PM
CONCANNON BRIANPresident & CEOJun 01Option Exercise32.684,500147,04551,171Jun 05 09:38 AM
CONCANNON BRIANPresident & CEOJun 01Sale68.514,500308,29448,171Jun 05 09:38 AM
open in yahoo | open in reuters | open in google